BackVirax Biolabs Group Overview

Virax Biolabs Group Total Liabilities

Virax Biolabs Group's total liabilities is $990K.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$989831.00
2.60% YoYΔ $25081.00 vs prior year quarter

Peer trimmed avg / median

Loading

Virax Biolabs Group Total Liabilities History

Loading

Virax Biolabs Group vs. peers: Total Liabilities Comparison

Loading

Virax Biolabs Group Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Virax Biolabs Group (VRAX) FAQ

As of the most recent data (March 2026), VRAX shows a total liabilities of $990K. That compares with $960K in the prior-year period — up 2.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, VRAX's total liabilities is now $990K (was $960K) — a 2.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Virax Biolabs Group is outperforming or lagging.

Tracking VRAX's total liabilities over time shows whether Virax Biolabs Group is scaling, shrinking, or reshaping that part of the business. The current reading is $990K That compares with $960K in the prior-year period — up 2.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Virax Biolabs Group's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $990K) with ownership activity and broader fundamentals.